ATROVENT sol inhal 250 mcg/2ml 60 monodos 2 ml

7680525840195 CH-52584 R03BB01 03.04.3.
ATROVENT sol inhal 250 mcg/2ml 60 monodos 2 ml
ATROVENT sol inhal 250 mcg/2ml 60 monodos 2 ml
ATROVENT sol inhal 250 mcg/2ml 60 monodos 2 ml
1 / 3
google

Details

Product number
5258401
CPT
-
Packaging group
60
Unit
Einzeldose(n)
Composition
ipratropii bromidum anhydricum 250 µg ut ipratropii bromidum, natrii chloridum, acidum hydrochloridum, aqua purificata ad solutionem pro 2 ml.

Articles (1)

Atrovent 250 mcg/2 ml, Lösung für einen Vernebler (gebrauchsfertige Einzeldosen)
Lösung
60
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
18/02/2025
Patient information leaflet
Français
18/02/2025
Patient information leaflet
Italien
18/02/2025
Professional SmPC
Allemand
18/02/2025
Professional SmPC
Français
18/02/2025
Professional SmPC
Italien
18/02/2025

Detailed composition

Substance Quantity Type Category
(N/A)
250.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 34.85
Specialties list
Yes
Generic
No
SL addition date: 01/02/2018

Authorization holder

Boehringer Ingelheim (Schweiz) GmbH

4057 Basel

Authorization information

Swissmedic authorization number
52584
Drug name
Atrovent, Lösung für einen Vernebler (gebrauchsfertige Einzeldosen)
Galenic form
LSVE
ATC Code
R03BB01
Authorization status
Z
Dispensation category
B
First authorization
15/11/1994
Authorization expiration date
31/12/9999
IT number
03.04.3.
Domain
Human medicine
Field of application
Bronchospasmolytikum

Packaging details

Description (FR)
ATROVENT sol inhal 250 mcg/2ml 60 monodos 2 ml
Description (DE)
ATROVENT Inhal Lös 250 mcg/2ml 60 Monodos 2 ml
Market launch
15/11/1994
Narcotic (BTM)
No

Other packaging sizes